Akira Nikaido

Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.

H. Morita, S. Fuke, T. Tada, 2010, International journal of cardiology.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention

K. Tanabe, Takeshi Kimura, Y. Ikari, 2021, Circulation. Cardiovascular interventions.

Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2

Takeshi Kimura, Y. Morino, T. Morimoto, 2020, Cardiovascular Intervention and Therapeutics.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention

K. Tanabe, Takeshi Kimura, Y. Ikari, 2021, Circulation. Cardiovascular interventions.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.

T. Morimoto, N. Watanabe, Ko Yamamoto, 2022, JACC. Cardiovascular interventions.

Perivascular fat attenuation index measured by coronary computed tomography angiography as a tool for assessment of ischaemia-causing lesions: a case report

Yoshiki Hata, Junji Mochizuki, S. Okamoto, 2023, BMC Cardiovascular Disorders.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.